Takeda Strengthens Global Research Infrastructure With Paradigm Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal will add U.K. firm’s target identification and validation capabilities to the Japanese firm’s research platform.
You may also be interested in...
Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences
Agreement is one of three announced by Takeda March 30, including a deal to develop cancer compounds with CanBas.
Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences
Agreement is one of three announced by Takeda March 30, including a deal to develop cancer compounds with CanBas.
Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences
Takeda has signed a global licensing and research collaboration agreement with South Korean company LG Life Sciences to discover, develop and commercialize anti-obesity drugs, the firms announced March 30